If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIntercede Regulatory News (IGP)

Share Price Information for Intercede (IGP)

Share Price is delayed by 15 minutes
Get Live Data
105.50    -2.50 (-2.31%)
Bid:
103.00
Ask:
108.00
Spread: 5.00 (4.854%)
Market Cap: £63.47m
IGP Live PriceLast checked at - London Stock Exchange

Intraday Intercede Share Chart

Trading Update

16 Feb 2012 07:00

RNS Number : 5149X
Intercede Group PLC
16 February 2012
 



16 February 2012

Intercede Group plc

("Intercede")

 

Trading Update

 

Intercede reports that the financial year ending 31 March 2012 will be profitable and cash generating. However, with six weeks to go before the end of the period, the order book of £6.3m stands at a similar position to the prior year. The Company's ability to book further orders before 31 March is dependent on a small number of projects in the pipeline receiving customer approval in sufficient time for deliveries to be made and revenue recognised.

In a challenging global economy, customers are moving to rental models that defer revenue recognition into future periods (with the potential to generate much higher medium term shareholder value from greater earnings visibility) and/or deferring project start dates. A number of large prospects have transitioned within the last six months from wishing to buy perpetual software licenses to specifying rental models, driven by market trends for Software as a Service (SaaS),at the expense of reducing current year revenue expectations. We continue to invest for growth as ID and Credentials Management remains a key priority for governments and enterprise. We see a continuing global pipeline of opportunities, which may be delayed, but not cancelled.

As at 10 February 2012 cash balances totalled £7.0m up from £6.6m reported on 30 September 2011.

Richard Parris, Intercede Chairman & Chief Executive, said:

"Whilst it is disappointing that short term revenues do not reflect the significant strategic and commercial progress made by Intercede, we nevertheless believe the business is in a better position to generate long term shareholder value. We are continuing to work to address any revenue gap in the current year but we are dependent on the buying behaviour of large government and corporate customers.

"In the period we have invested according to plan to reinforce our positioning with major partners such as Microsoft, extended our product reach into the smart phone market and are poised to participate in a number of high volume managed service projects.

"To fully exploit the growth opportunity we have created, Intercede has also appointed an international sales director, increased our marketing expenditure, invested in a new website, engaged with UKTI to drive export sales into new markets and extended our US office.

"We will issue a further update on trading in early April."

###

 

ENQUIRIES

 

Intercede Group plc

Tel. +44 (0)1455 558111

Richard Parris, Chairman & Chief Executive

Andrew Walker, Finance Director

FinnCap

Tel. + 44 (0)20 7220 0500

Sarah Wharry

Rose Herbert

Pelham Bell Pottinger

Tel. +44 (0)20 7861 3112

Archie Berens

Clare Gilbey

 

About Intercede

Intercede is the producer of the MyID® identity and credential management system (IDCMS), the MyID Management Agent for Microsoft® Forefront™ Identity Manager and a range of mobile applications for securing smartphones.

The company's website has recently been re-launched to better reflect its enhanced proposition. For more information visit www.intercede.com, email info@intercede.com or call +44 (0)1455 558111.

MyID technology is being used around the world by large corporations, governments and banks to manage millions of identities for employees, citizens and customers. Notable deployments in the US include 14 federal agencies, two million smart cards in support of the US Transportation Worker Identity Credential program (TWIC), four US financial institutions and 340,000 smart corporate identity badges for Boeing, Booz Allen Hamilton and Lockheed Martin. In Europe, Australasia and the Middle East, MyID is being deployed in support of government identity, financial services, healthcare and corporate employee ID security projects.

MyID is the only IDCMS software product that enables organizations to easily and securely manage the identities of people, secure devices and their associated credentials within a single, integrated, workflow driven platform. This includes enabling and managing secure registration, biometric capture, application vetting and approval through to smart card and smartphone personalization, issuance and management.

At the forefront of the secure identity field, Intercede also offers innovative new solutions for smartphones, including secure email, physical and logical access, identity verification via near field communications and attribute management. With the trend towards 'bring your own device' in the workplace and the move to cloud-based services, MyID allows organizations to embrace new and more convenient approaches to security.

MyID was the first electronic personalization product to achieve compliance with the US FIPS-201 Personal Identity Verification (PIV) standard and is widely deployed by federal agencies, government contractors and other commercial entities. In particular, it supports the latest standards applicable for all PIV, PIV-Interoperable and PIV-Compatible (CIV) deployments.

MyID provides customers with a platform that can meet their needs now and in the future. It is a fully supported commercial off-the-shelf product that can be quickly deployed for thousands or millions of users.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTSFUFWIFESEIE
Date   Source Headline
15th Sep 20212:09 pmRNSResult of AGM
15th Sep 20217:00 amRNSMultiple Customers choose to Upgrade MyID
20th Jul 20217:00 amRNSIntercede achieves FIDO2 certification
5th Jul 20217:00 amRNSConnect Partner Programme & Q1 Contract Wins
15th Jun 20218:26 amRNSIssue of Equity
8th Jun 20217:00 amRNSFinal Results
2nd Jun 202110:09 amRNSInvestor Presentation
10th May 20217:00 amRNSShare Incentive Plan
7th Apr 20217:00 amRNSTrading Update & Appointment of Auditor
1st Apr 202110:30 amRNSReceipt of $3.4m Order
10th Mar 20217:00 amRNSShare Incentive Plan
23rd Feb 20217:00 amRNSAmendment to LTIP
22nd Feb 20214:10 pmRNSHolding(s) in Company
16th Feb 20217:00 amRNSCLN Conversion to Equity
12th Feb 20217:00 amRNSHolding(s) in Company
8th Feb 202112:40 pmRNSHolding(s) in Company
4th Feb 20217:00 amRNSCLN Call & Issue of Equity
11th Jan 20217:00 amRNSNew Contract Win
5th Jan 202111:00 amRNSCLN Conversion to Equity
4th Jan 202110:40 amRNSHolding(s) in Company
22nd Dec 20207:00 amRNSNew Contract Win
24th Nov 20207:00 amRNSHalf-year Report
17th Nov 20207:00 amRNSContract Win: Follow-on Purchase Order
12th Nov 20207:00 amRNSInvestor Presentation
8th Oct 20207:01 amRNSIntercede join the FIDO Alliance
8th Oct 20207:00 amRNSTrading Update
16th Sep 20203:40 pmRNSResult of AGM
20th Aug 20207:05 amRNSContract Win - Initial Progress Order
5th Aug 20202:01 pmRNSHolding(s) in Company
30th Jul 20207:00 amRNSContract Win
2nd Jun 20207:00 amRNSFinal Results
12th May 20207:00 amRNSShare Incentive Plan
20th Apr 202010:02 amRNSDirector/PDMR Shareholding
14th Apr 20207:00 amRNSDirector/PDMR Shareholding
7th Apr 20207:00 amRNSTrading Update
3rd Apr 20205:07 pmRNSShare Incentive Plan
31st Mar 20207:00 amRNSReceipt of $4.6m Order
28th Feb 20207:00 amRNSShare Incentive Plan
26th Feb 20209:50 amRNSShare Incentive Plan
25th Feb 20207:00 amRNSShare Incentive Plan
12th Feb 202011:22 amRNSShare Award
25th Nov 20197:00 amRNSHalf-year Report
7th Oct 20197:00 amRNSTrading Update
30th Sep 20197:00 amRNSDirector/PDMR Shareholding
18th Sep 20196:30 pmRNSResult of AGM
16th Sep 20193:56 pmRNSPosting of Annual Report & Notice of AGM
17th Jun 20197:00 amRNSAppointment of Non-Executive Director
5th Jun 20197:00 amRNSFinal Results
8th Apr 20197:00 amRNSSale of Property
2nd Apr 20197:00 amRNSTrading Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.